Drug target could block brain inflammation linked to Alzheimer’s and Parkinson’s

Blocking a receptor called P2X7 has been found to significantly reduce inflammation in human brain tissue, revealing a potential new treatment strategy for neurological and psychiatric disorders.

This discovery could help researchers repurpose existing drugs for conditions such as traumatic brain injury, Alzheimer’s, Parkinson’s, depression, and schizophrenia.